BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2208131)

  • 1. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
    Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
    Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea.
    Azuma M; Momose H; Oyasu R
    Cancer Res; 1990 Nov; 50(21):7062-7. PubMed ID: 2208174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model.
    Steinberg GD; Brendler CB; Squire RA; Isaacs JT
    J Urol; 1991 Mar; 145(3):647-53. PubMed ID: 1997724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine.
    Oyasu R; Iwasaki T; Matsumoto M; Hirao Y; Tabuchi Y
    Cancer Res; 1978 Sep; 38(9):3019-25. PubMed ID: 679209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from low grade to high grade of rat urinary bladder carcinomas.
    Samma S; Oyasu R
    Cancer Res; 1988 Mar; 48(5):1265-9. PubMed ID: 3342406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus.
    Kawai K; Kawamata H; Kemeyama S; Rademaker A; Oyasu R
    Cancer Res; 1994 May; 54(10):2630-2. PubMed ID: 8168089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats.
    Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC
    Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
    Perabo FG; Demant AW; Wirger A; Schmidt DH; Sitia M; Wardelmann E; Müller SC; Kohn EC
    Anticancer Res; 2005; 25(2A):725-9. PubMed ID: 15868902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of bladder cancer.
    Friedell GH; Jacobs JB; Nagy GK; Cohen SM
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
    Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversibility of low-grade superficial rat bladder carcinomas.
    Ozono S; Numata I; Oyasu R
    Cancer Res; 1984 Oct; 44(10):4260-2. PubMed ID: 6467186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.